ArticleJournal of the American College of Emergency Physicians open2026
Emergency Department Visits in the United States for Paroxysmal Supraventricular Tachycardia Are Increasing Among Adults: An Analysis from the Nationwide Emergency Department Sample.
Article in Journal of the American College of Emergency Physicians open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Paroxysmal supraventricular tachycardia (PSVT) is an arrhythmia that may be challenging to diagnose because of its sudden and episodic nature and its presentation, which may be confused with acute anxiety, especially after spontaneous resolution. Prevalence of PSVT in the United States (US), based on projections to the 2018 US Census, was estimated to be as high as 2.1 million patients with an annual incidence of nearly 300,000. Prior studies report significant rates of health-care resource use among newly diagnosed patients with PSVT, but likely do not reflect contemporary acute care utilization in a population with increased PSVT prevalence. In this study, we quantified annual US emergency department (ED) visits for PSVT and examined temporal trends in PSVT across time among adults aged ≥18 years old. Methods: We used the Nationwide Emergency Department Sample data to identify adults who visited the ED with a primary diagnosis of PSVT (International Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM]: I47.1) from 2016-2019. We used Agency for Healthcare Research and Quality-provided sampling weights to estimate annual ED visit counts in the US overall and by the presence or absence of comorbid atrial fibrillation (AFib)/atrial flutter (AFl). We examined demographic characteristics, calculated annual visit rates per 10,000 US population, and assessed visit trends 2016-2019. Sensitivity analyses were conducted in which ED visits were defined primarily for PSVT when PSVT was the primary diagnosis and the ED visit resulted in hospitalization or when PSVT was the diagnosis in any position, and the visit resulted in discharge. We used Poisson regression, based on 2016-2019 visit increases, to project estimates of PSVT visits through 2030. Results: ED visits for PSVT increased 8.3% over the study period (from 129,219 to 139,992; Conclusion: ED visits due to PSVT in the US have increased significantly among adults. Outpatient interventions for PSVT that reduce the need for an ED visit may minimize the economic burden of PSVT for patients, providers, and payers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.